News

Director Michael B. Hoffman filed a Form 4 with the SEC on November 6, 2026, disclosing the acquisition of 5,000,000 shares of Annovis Bio, Inc. common stock and 5,000,000 warrants on that same date.

Director Jorge L. Benitez of World Kinect Corp filed a Form 4 on November 6, 2026, disclosing the sale of 18,000 shares of common stock across two transactions on November 4 and November 5, 2026.

Director Christopher D. Brown of 908 Devices Inc. filed a Form 4 on November 6, 2026, disclosing the sale of 30,000 shares of common stock on November 4, 2026, under a pre-established Rule 10b5-1 trading plan.

Robert F. Mehmel, President and Chief Operating Officer of Griffon Corporation, filed a Form 4 on November 6, 2026, disclosing the sale of common stock on November 5, 2026.

Intercontinental Exchange, Inc. Global Head of Clearing and Chief Risk Officer Elizabeth Kathryn King filed a Form 4 on November 6, 2026, disclosing the sale of 1,919 shares of common stock on November 4, 2026.

Benjamin Jackson, President of Intercontinental Exchange, Inc., filed a Form 4 on November 6, 2026, disclosing two open-market sales of common stock totaling 7,732 shares on November 4 and November 5, 2026, executed under a pre-established Rule 10b5-1 trading plan.

James W. Namkung, Chief Accounting Officer of Intercontinental Exchange, Inc., filed a Form 4 on November 6, 2026, disclosing a sale of 3,777 shares of common stock on November 4, 2026, executed under a pre-established Rule 10b5-1 trading plan.